Duality Biotherapeutics, Inc. (HKG:9606)
346.40
-1.00 (-0.29%)
Jan 21, 2026, 1:25 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 31.06 billion as of January 20, 2026.
Market Cap
31.06B
Enterprise Value
27.07B
Revenue
2.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
346.40
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 31.06B, an increase of 77.36%. That is a compound annual growth rate of 111.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 31.06B | 16.50% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 212.13B |
| WuXi Biologics | 156.50B |
| Innovent Biologics | 148.05B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 110.48B |